Sponsor
University of Leicester
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name University of Leicester appears in 95 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownMake Every Step Count: Personalised Music Feedback to Walking for People Living With COPDNCT06629675 · lead sponsor · 2025-04-20
RECRUITINGThe Role of Epicardial Adiposity in Heart Failure With Preserved Ejection FractionNCT06768437 · lead sponsor · 2025-02-12
RECRUITINGManganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection FractionNCT06652763 · lead sponsor · 2024-10-10
RECRUITINGA Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes MellitusNCT06471634 · lead sponsor · 2024-09-02
RECRUITINGBrain Training to Improve Balance in Parkinson's DiseaseNCT05986643 · lead sponsor · 2023-08-04
RECRUITINGStudy of Hospitalised Patients With Acute Respiratory ConditionsNCT05095090 · lead sponsor · 2022-02-02
RECRUITINGThe Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · lead sponsor · 2020-03-10
RECRUITINGValidating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis PatientsNCT03586518 · lead sponsor · 2019-11-03
RECRUITINGPrevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes MellitusNCT03132129 · lead sponsor · 2017-10-24
RECRUITINGChronotype of Patients With Diabetes and Effect on Glycaemic ControlNCT02973412 · lead sponsor · 2016-12-07
RECRUITINGDiabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular DysfunctionNCT02590822 · lead sponsor · 2015-10-02
RECRUITINGEffectiveness of Pollution Monitoring in Clinical Exercise RehabilitationNCT07500948 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGActive Airways for Children and Young People With AsthmaNCT07643753 · lead sponsor · 2026-07-01
NOT_YET_RECRUITINGDisease Modification Outcomes in Diabetes: a Delphi StudyNCT07201532 · lead sponsor · 2025-09-01
NOT_YET_RECRUITINGRemote Ischaemic Conditioning (RIC) in Heart FailureNCT06616233 · lead sponsor · 2024-04-08
UNKNOWNFOOTSAK (Footwear Self-Assessment Kit)NCT06200532 · lead sponsor · 2024-03-21
COMPLETEDThe Sarcopenia StudyNCT05888688 · lead sponsor · 2023-12-06
UNKNOWNSGLT-i Use in Diabetic Foot Ulcer DiseaseNCT06000722 · lead sponsor · 2023-12-05
COMPLETEDA Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection FractionNCT05887271 · lead sponsor · 2023-12-05
COMPLETEDDeveloping Personalised Relative Physical Activity Thresholds in COPD.NCT06330623 · lead sponsor · 2023-11-22
COMPLETEDAnxiety Management in Breathlessness.NCT06066658 · lead sponsor · 2023-10-01
UNKNOWNUsability and Acceptability Study of the P-STEP Mobile ApplicationNCT05830318 · lead sponsor · 2023-08-23
COMPLETEDRole of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPDNCT05814484 · lead sponsor · 2023-08-10
UNKNOWN3D Foot Scanner Reliability for Footwear Fit and DesignNCT05676619 · lead sponsor · 2023-02-16
COMPLETEDA Holistic Patient-centred Intervention to Improve Outcomes of Older People Living With Frailty and Chronic Heart FailureNCT06386640 · lead sponsor · 2023-01-27
UNKNOWNThe Minuteful Kidney Test Evaluation: A Randomised Controlled TrialNCT05967312 · lead sponsor · 2022-11-18
UNKNOWNAn Analysis to Assess Non-adherence in People With Type 2 DiabetesNCT05256875 · lead sponsor · 2022-08-30
TERMINATEDOptimising CMR Scan Acquisitions for Novel Equipment/Sequences in Clinical Cardiovascular Populations.NCT06311552 · lead sponsor · 2022-01-31
COMPLETEDImpact of Hybrid Closed Loop Systems in People With Type I DiabetesNCT05348499 · lead sponsor · 2021-11-14
UNKNOWNMeasuring sVAP-1 as a Predictor of Pregnancy ProblemsNCT04891315 · lead sponsor · 2021-07-25
TERMINATEDPhenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis StudyNCT04815850 · lead sponsor · 2021-03-01
COMPLETEDRed Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac SurgeryNCT03167788 · lead sponsor · 2020-12-01
WITHDRAWNMepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialNCT04075331 · lead sponsor · 2020-09-07
COMPLETEDCOPD in the Time of COVID-19NCT04407598 · lead sponsor · 2020-05-01
UNKNOWNFeasibility of Low Energy Diet in HFpEF and Type 2 DiabetesNCT04173117 · lead sponsor · 2020-02-28
TERMINATEDCR: Developing an Intervention to Improve Acceptance of Referral in HFNCT04276675 · lead sponsor · 2020-02-05
COMPLETEDThe PRE-OP ENERGY TrialNCT04015973 · lead sponsor · 2019-05-07
UNKNOWNDobutamine vs Adenosine CMR StudyNCT03661827 · lead sponsor · 2019-02-05
COMPLETEDMesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant MesotheliomaNCT03654833 · lead sponsor · 2019-01-28
COMPLETEDThe Cognition and Flow StudyNCT03656107 · lead sponsor · 2019-01-14
TERMINATEDThe Multi-Ethnic Lifestyle StudyNCT04256720 · lead sponsor · 2018-12-10
UNKNOWNThe Val-CARD TrialNCT03825250 · lead sponsor · 2018-11-06
TERMINATEDInvestigating the Acute Effect of Alternative Forms of Physical Activity in a Multi-ethnic PopulationNCT03549390 · lead sponsor · 2018-10-30
COMPLETEDAnti-ST2 (MSTT1041A) in COPD (COPD-ST2OP)NCT03615040 · lead sponsor · 2018-10-11
COMPLETEDThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 DiabetesNCT04219124 · lead sponsor · 2018-09-20
COMPLETEDUpregulating the Nitric Oxide Pathway To Restore Autonomic Phenotype (UNTRAP).NCT03658174 · lead sponsor · 2018-08-30
COMPLETEDCardiac Rest and Stress Metabolism in Patients With Type 2 DiabetesNCT04009642 · lead sponsor · 2018-03-05
COMPLETEDThe Effects of Reducing Prolonged Sitting Bouts in Individuals at High Risk of or With Type 2 DiabetesNCT03482596 · lead sponsor · 2018-02-21
COMPLETEDSaxenda in Obesity Services (STRIVE Study)NCT03036800 · lead sponsor · 2017-11-28
COMPLETEDAnalysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020NCT04256044 · lead sponsor · 2017-11-23
COMPLETEDThe Effects of an 8-week Vegan Diet on TMAO Levels and Post-challenge Glucose Levels in Individuals With DysglycaemiaNCT03315988 · lead sponsor · 2017-10-04
COMPLETEDCerebral Haemodynamic Changes During Cognitive Testing: A fTCD StudyNCT03134963 · lead sponsor · 2017-05-05
COMPLETEDExhaled Breath Metabolomic Biomarkers in the Acutely Breathless PatientNCT03672994 · lead sponsor · 2017-02-02
COMPLETEDSGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.NCT02798744 · lead sponsor · 2016-12-01
COMPLETEDFormat of Patient Education for Different Sociodemographic GroupsNCT02961517 · lead sponsor · 2016-12-01
UNKNOWNRefractory Asthma Stratification Programme (RASP) Bronchoscopy StudyNCT02883530 · lead sponsor · 2016-09-26
UNKNOWNA Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac SurgeryNCT02908009 · lead sponsor · 2016-09-09
UNKNOWNRight Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic ResonanceNCT02865577 · lead sponsor · 2016-07-02
COMPLETEDCanagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During RamadanNCT02694263 · lead sponsor · 2016-07-01
COMPLETEDChildhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry TestingNCT02913872 · lead sponsor · 2016-06-01
COMPLETEDSponsor roles
lead sponsor76
collaborator19
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.